Skip to main content
Premium Trial:

Request an Annual Quote

Frances Heller

Frances Heller has joined Diagnostics For All's board, effective immediately. She currently is a trustee of the Dana-Farber Cancer Institute and a board member at Zafgen and Affinivax. Heller most recently was senior vice president of business development at Bristol-Myers Squibb and was a trustee of the Bristol-Myers Squibb Foundation. Before joining Bristol-Myers Squibb, she was executive vice president of business development at Exelixis Pharmaceuticals.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.